Product Information
THYROID 15 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.5188 per EA under NDC 69680016500. Its NADAC has been published 75 times since Mar 19, 2025.
Strength
15 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680016500
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
THYROIDApproval Type
Unapproved
On Market Since
11/22/2024
Price Statistics
The NADAC for THYROID 15 MG TABLET has been published 75 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5188 per EA |
|---|---|
| All-time high | $0.5373 (Jul 16, 2025) |
| All-time low | $0.5134 (Jun 17, 2026) |
| 52-week high | $0.5312 |
| 52-week low | $0.5134 |
| Median price | $0.5261 |
| Average price | $0.5253 |
| Largest weekly change | -1.8% (Apr 22, 2026) |
| Weeks tracked | 75 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the THYROID market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of THYROID 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THYROID 15 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $0.5188 per EA (NDC 69680016500), effective Aug 19, 2026.
How has the price of THYROID 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for THYROID 15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 75 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for THYROID 15 MG TABLET?
Since Mar 19, 2025, the NADAC for THYROID 15 MG TABLET has ranged from a low of $0.5134 (Jun 17, 2026) to a high of $0.5373 (Jul 16, 2025), with a median of $0.5261 per EA.
Are there cheaper alternatives to THYROID 15 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of THYROID 15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures THYROID 15 MG TABLET?
THYROID 15 MG TABLET (NDC 69680016500) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.